Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05102240 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Development of Clinically High Efficient Platforms for Individualised Treatment of Cervix Cancer

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 20, 2026 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Trial status: Active, Not Recruiting to Recruiting Site details revisedv7 Show 1 more changeShow less
    • Site details revised
  2. Re-verified, no change to tracked fieldsv6
  3. Primary and study completion dates: Sep 2024 to Jun 30, 2026v5
  4. Re-verified, no change to tracked fieldsv4
  5. Trial status: Not Yet Recruiting to Active, Not Recruiting Start date changed from estimate of Feb 2022 to Feb 24, 2022v3 Show 1 more changeShow less
    • Start date changed from estimate of Feb 2022 to Feb 24, 2022
  6. Start date: Oct 2021 to Feb 2022 Study description expanded, about 3 wordsv2 Show 1 more changeShow less
    • Study description expanded, about 3 words

    See this version in full on ClinicalTrials.gov ↗

  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Retrospective study utilizing patient data to develop and validate Machine Learning application. Available imaging data sets of patients who have completed treatment will be used to develop Normal tissue complication probability and Tumour control probability Hypothesis Integrating existing radiation treatment information, quantitative imaging and patient outcome data from completed and ongoing clinical trials will allow development of knowledge based systems for efficient treatment delivery and allow selection of patients for intensified treatment approaches in cervix cancer.
Trial Details
NCT Number NCT05102240
Lead Sponsor Tata Memorial Hospital
Collaborators: Bhabha Atomic Research Centre, Erasmus Medical Center
Conditions Cervix Cancer
Enrollment 1,800 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov